Biogen BIIB
NASDAQ BIIB
$250.69 -3.15 (-1.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Biogen (BIIB) Selling, General & Administrative (2009 - 2026)

Updated

Biogen's Selling, General & Administrative came in at $709.7 million for Q2 2026, up 21.6% from $583.8 million a year earlier and up 16.9% from the prior quarter.

Analysis

Biogen (BIIB) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Biogen reported Selling, General & Administrative of $2.59 billion, up 7.0% year-over-year; for FY2025, it was $2.43 billion, up 1.2% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $2.4 billion in FY2024 (-5.7%), $2.55 billion in FY2023 (+6.1%), $2.4 billion in FY2022 (-10.1%) and $2.67 billion in FY2021 (+6.8%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative since Q3 2023.
  • Year-over-year, Selling, General & Administrative has increased for five consecutive quarters, with growth averaging 2.4% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2023 (growth of 39.9%), and the weakest in Q3 2024 (a decline of 25.3%).
  • Business Quant data shows BIIB's Selling, General & Administrative at $607.3 million (Q1 2026), $682.5 million (Q4 2025) and $594.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 6.29 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 3.63 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 3.41 Bn
10 Biogen 37.04 Bn 23.70 Bn 1.96 Bn 709.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 709.70 Mn
Mar 31, 2026 607.30 Mn
Dec 31, 2025 682.50 Mn
Sep 30, 2025 594.80 Mn
Jun 30, 2025 583.80 Mn
Mar 31, 2025 572.50 Mn
Dec 31, 2024 680.00 Mn
Sep 30, 2024 588.40 Mn
Jun 30, 2024 553.80 Mn
Mar 31, 2024 581.50 Mn
Dec 31, 2023 608.50 Mn
Sep 30, 2023 788.20 Mn
Jun 30, 2023 548.00 Mn
Mar 31, 2023 605.00 Mn
Dec 31, 2022 632.80 Mn
Sep 30, 2022 563.30 Mn
Jun 30, 2022 572.60 Mn
Mar 31, 2022 634.90 Mn
Dec 31, 2021 787.90 Mn
Sep 30, 2021 654.10 Mn
API Access

Biogen Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BIIB&period=max&api_key=YOUR_API_KEY